NEW YORK (GenomeWeb) – Exosome Diagnostics announced today that it has partnered with Amgen to develop a liquid biopsy test.

Under the terms of the deal, the companies will use Exosome's technology to identify a potential liquid biopsy diagnostic that may be used in Amgen's drug development processes. Additional terms of the arrangement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.